Feasibility Pilot of Bright Light in the Intensive Care Unit
Completed · Not applicable
Conditions studied: Circadian Rhythm Sleep Disorder, Unspecified
In brief
To evaluate the feasibility of providing daytime bright light in the ICU in a pilot randomized controlled trial.
Key facts
- Study ID
- NCT03568045
- Run by
- Yale University
- People needed
- 16
- Starts
- 2018-12-03
- Expected to finish
- 2024-03-31
- Last updated by the study team
- 2024-06-17
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Hospital admission ≤30 hours at noon on enrollment day
- Expected to say in the Medical Intensive Care Unit ≥24 hours after enrollment
- Age ≥50 years
- History of hypertension based on chart review and presence of 1 or more home blood pressure medications
- Able to understand English
You may not qualify if…
- At significant risk for pre-existing circadian abnormalities:
- Severe chronic brain injury (Injury greater than 30 days ago resulting in the inability to live independently) OR Acute brain injury of any severity (Injury less than 30 days ago including acute intracranial bleed, traumatic brain injury, central nervous system infection, tumor)
- Documented circadian disorder (<1% population) or blind/disease of the optic nerve
- Current history of substance abuse including alcohol (use in last 30 days)
- Current or recent (last 1 year) shiftwork
- Home medications include: melatonin, melatonin agonist
- Transferred from an outside hospital, long-term care, rehabilitation, or acute care facility
- History of bipolar disease (Bright light therapy possibly unsafe in this population).
- Paralyzed (due to injury, disease or medications)
- Diagnosed with hepatic encephalopathy in the setting of end-stage liver disease
- Homeless
Where it is running
- Yale New Haven Hospital, York Street Campus — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.